Redmile Group’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-525,575
Closed -$31.9M 71
2022
Q3
$31.9M Sell
525,575
-210,600
-29% -$6.66M 1.24% 28
2022
Q2
$20M Hold
736,175
0.76% 36
2022
Q1
$26.9M Sell
736,175
-29,500
-4% -$1.06M 0.84% 35
2021
Q4
$37.8M Sell
765,675
-135,816
-15% -$7.53M 0.86% 34
2021
Q3
$64.2M Sell
901,491
-314,166
-26% -$19.5M 1.12% 28
2021
Q2
$62.5M Sell
1,215,657
-641,415
-35% -$20M 0.92% 34
2021
Q1
$46.6M Buy
+1,857,072
New +$34.9M 0.66% 46
2017
Q3
Sell
-509,698
Closed -$27.6M 72
2017
Q2
$27.6M Sell
509,698
-339,785
-40% -$18.1M 1.68% 22
2017
Q1
$47.4M Buy
849,483
+195,758
+30% +$10.3M 3.08% 9
2016
Q4
$32.2M Sell
653,725
-47,934
-7% -$2.64M 2.77% 13
2016
Q3
$42.1M Buy
701,659
+214,253
+44% +$11.5M 3.35% 12
2016
Q2
$17M Buy
+487,406
New +$21.2M 1.63% 25
2014
Q4
Sell
-125,973
Closed -$2.79M 60
2014
Q3
$2.79M Sell
125,973
-244,547
-66% -$5.18M 0.32% 49
2014
Q2
$8.36M Sell
370,520
-189,091
-34% -$4.73M 1.01% 37
2014
Q1
$21.4M Buy
559,611
+550,511
+6,050% +$17.7M 2.56% 14
2013
Q4
$241K Buy
+9,100
New +$228K 0.03% 53

Other funds holding PRTA

Redmile Group's PRTA Position: Q4 2022 in Review

Redmile Group sold out of Prothena Corp (PRTA) in Q4 2022, closing a stake of 525,575 shares — an estimated $31.9M sold.

Redmile Group first reported a position in PRTA in Q4 2013 and held it in 16 quarters. The position peaked at $64.2M in Q3 2021. 201 funds tracked by Wall St. Rank hold PRTA as of Q4 2022.

  • Redmile Group reported no remaining Prothena Corp position as of Q4 2022 after selling out during the quarter.
  • Redmile Group sold 525,575 Prothena Corp shares in Q4 2022, an estimated $31.9M.
  • Redmile Group first reported a position in Prothena Corp in Q4 2013 and held it in 16 quarters.
  • Redmile Group's Prothena Corp position peaked at $64.2M in Q3 2021.
  • 201 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2022.

Based on Redmile Group's 13F filing for Q4 2022, filed 14 Feb 2023.